Miyuki Funami

1.0k total citations
15 papers, 774 citations indexed

About

Miyuki Funami is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Miyuki Funami has authored 15 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Oncology. Recurrent topics in Miyuki Funami's work include Diabetes Treatment and Management (7 papers), Receptor Mechanisms and Signaling (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Miyuki Funami is often cited by papers focused on Diabetes Treatment and Management (7 papers), Receptor Mechanisms and Signaling (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Miyuki Funami collaborates with scholars based in Japan and United States. Miyuki Funami's co-authors include Takahiro Funami, Yuki Nakao, Nobuhiro Suzuki, Takashi Santou, Tsuneo Yasuma, Nobuyuki Negoro, Naoyuki Kanzaki, Yū Momose, Yoshiyuki Tsujihata and Masami Suzuki and has published in prestigious journals such as Journal of Medicinal Chemistry, Food Hydrocolloids and Journal of Food Science.

In The Last Decade

Miyuki Funami

15 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miyuki Funami Japan 13 400 321 193 174 114 15 774
Catherine Chapus France 16 743 1.9× 214 0.7× 264 1.4× 39 0.2× 56 0.5× 36 1.0k
Tomoko Asakawa Japan 14 385 1.0× 450 1.4× 171 0.9× 126 0.7× 243 2.1× 17 885
Hee Jeong Seo South Korea 15 192 0.5× 53 0.2× 31 0.2× 234 1.3× 90 0.8× 26 531
Margherita Lapillo Italy 15 335 0.8× 50 0.2× 47 0.2× 69 0.4× 60 0.5× 17 514
Malin Hult Sweden 10 506 1.3× 268 0.8× 71 0.4× 39 0.2× 12 0.1× 13 896
Gary Sidhu Canada 7 505 1.3× 90 0.3× 19 0.1× 189 1.1× 10 0.1× 10 821
Mohd Rehan Ajmal India 8 350 0.9× 52 0.2× 17 0.1× 58 0.3× 16 0.1× 11 603
Sonia Gascón Spain 14 165 0.4× 43 0.1× 48 0.2× 178 1.0× 8 0.1× 26 588
Katerina Otrubova United States 12 299 0.7× 40 0.1× 59 0.3× 172 1.0× 38 0.3× 15 563
Zhinan Mei China 13 223 0.6× 144 0.4× 23 0.1× 42 0.2× 9 0.1× 20 482

Countries citing papers authored by Miyuki Funami

Since Specialization
Citations

This map shows the geographic impact of Miyuki Funami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Funami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Funami more than expected).

Fields of papers citing papers by Miyuki Funami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyuki Funami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Funami. The network helps show where Miyuki Funami may publish in the future.

Co-authorship network of co-authors of Miyuki Funami

This figure shows the co-authorship network connecting the top 25 collaborators of Miyuki Funami. A scholar is included among the top collaborators of Miyuki Funami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyuki Funami. Miyuki Funami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Iwasaki, Shinji, Hideki Hirabayashi, Miyuki Funami, & Nobuyuki Amano. (2016). Unbound liver concentration is the true inhibitor concentration that determines cytochrome P450-mediated drug–drug interactions in rat liver. Xenobiotica. 47(6). 488–497. 6 indexed citations
3.
Yamashita, Takashi, Asato Kina, Masaaki Funata, et al.. (2012). Design, synthesis, and structure–activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(11). 3643–3647. 46 indexed citations
4.
Yamashita, Takashi, Asato Kina, Michiko Tawada, et al.. (2012). Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(14). 4769–4772. 35 indexed citations
5.
Mikami, Satoshi, Shuji Kitamura, Nobuyuki Negoro, et al.. (2012). Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 55(8). 3756–3776. 47 indexed citations
7.
Negoro, Nobuyuki, Shinobu Sasaki, Masahiro Ito, et al.. (2012). Identification of Fused-Ring Alkanoic Acids with Improved Pharmacokinetic Profiles that Act as G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonists. Journal of Medicinal Chemistry. 55(4). 1538–1552. 58 indexed citations
8.
Maezaki, Hironobu, Yasufumi Miyamoto, Tomoko Asakawa, et al.. (2011). Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554. Bioorganic & Medicinal Chemistry. 19(15). 4482–4498. 28 indexed citations
9.
Sasaki, Shinobu, Shuji Kitamura, Nobuyuki Negoro, et al.. (2011). Design, Synthesis, and Biological Activity of Potent and Orally Available G Protein-Coupled Receptor 40 Agonists. Journal of Medicinal Chemistry. 54(5). 1365–1378. 75 indexed citations
10.
Miyamoto, Yasufumi, Mitsuru Sasaki, Satoru Oi, et al.. (2011). Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554. Bioorganic & Medicinal Chemistry. 19(16). 4953–4970. 40 indexed citations
11.
Miyamoto, Yasufumi, Takashi Yamashita, Tatsuhiko Fujimoto, et al.. (2010). Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125. Bioorganic & Medicinal Chemistry. 19(1). 172–185. 23 indexed citations
12.
Negoro, Nobuyuki, Shinobu Sasaki, Satoshi Mikami, et al.. (2010). Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist. ACS Medicinal Chemistry Letters. 1(6). 290–294. 210 indexed citations
13.
Funami, Takahiro, et al.. (2000). A rheological study on the effects of heating rate and dispersing method on the gelling characteristics of curdlan aqueous dispersions. Food Hydrocolloids. 14(5). 509–518. 36 indexed citations
14.
Funami, Takahiro, et al.. (1999). Decreasing Oil Uptake of Doughnuts During Deep‐fat Frying Using Curdlan. Journal of Food Science. 64(5). 883–888. 51 indexed citations
15.
Funami, Takahiro, et al.. (1999). Rheological and thermal studies on gelling characteristics of curdlan. Food Hydrocolloids. 13(4). 317–324. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026